Free Trial

Cosmo Pharmaceuticals (CMOPF) Short Interest Ratio & Short Volume

Cosmo Pharmaceuticals logo
C$75.00 0.00 (0.00%)
As of 08/29/2025

Cosmo Pharmaceuticals Short Interest Data

Cosmo Pharmaceuticals (CMOPF) has a short interest of 27,000 shares. This marks a -34.47% decrease in short interest from the previous month. The short interest ratio (days to cover) is 67.5, indicating that it would take 67.5 days of the average trading volume of 438 shares to cover all short positions.

Current Short Interest
27,000 shares
Previous Short Interest
41,200 shares
Change Vs. Previous Month
-34.47%
Dollar Volume Sold Short
$2.03 million
Short Interest Ratio
67.5 Days to Cover
Last Record Date
July 31, 2025
Today's Trading Volume
0 shares
Average Trading Volume
438 shares
Today's Volume Vs. Average
0%
Short Selling Cosmo Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Cosmo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

CMOPF Short Interest Over Time

CMOPF Days to Cover Over Time

CMOPF Percentage of Float Shorted Over Time

Cosmo Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202527,000 shares C$2.03 million -34.5%N/A67.5 $75.00
7/15/202541,200 shares C$3.21 million +25.2%N/A206 $77.88
6/30/202532,900 shares C$2.12 million -8.1%N/A0 $64.37
6/15/202535,800 shares C$2.30 million -5.3%N/A0 $64.37
5/31/202537,800 shares C$2.43 million -12.5%N/A378 $64.37
5/15/202543,200 shares C$2.38 million -35.0%N/A0 $55.00
4/30/202566,500 shares C$3.66 million -4.7%N/A0 $55.00
4/15/202569,800 shares C$3.84 million -4.6%N/A174.5 $55.00
3/14/202590,500 shares C$6.65 million +45.5%N/A452.5 $73.50
2/28/202562,200 shares C$4.57 million +2.1%N/A622 $73.50
2/14/202560,900 shares C$4.42 million +3.6%N/A609 $72.50
1/31/202558,800 shares C$4.16 million +0.2%N/A294 $70.70
1/15/202558,700 shares C$3.93 million -10.0%N/A0 $66.93

CMOPF Short Interest - Frequently Asked Questions

What is Cosmo Pharmaceuticals' current short interest?

Short interest is the volume of Cosmo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 27,000 shares of CMOPF short. Learn More on Cosmo Pharmaceuticals' current short interest.

What is a good short interest ratio for Cosmo Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMOPF shares currently have a short interest ratio of 68.0. Learn More on Cosmo Pharmaceuticals's short interest ratio.

Is Cosmo Pharmaceuticals' short interest increasing or decreasing?

Cosmo Pharmaceuticals saw a decline in short interest in July. As of July 31st, there was short interest totaling 27,000 shares, a decline of 34.5% from the previous total of 41,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cosmo Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Cosmo Pharmaceuticals: Otsuka Holdings Co., Ltd. - Unsponsored ADR (0.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Cosmo Pharmaceuticals stock?

Short selling CMOPF is an investing strategy that aims to generate trading profit from Cosmo Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cosmo Pharmaceuticals?

A short squeeze for Cosmo Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMOPF, which in turn drives the price of the stock up even further.

How often is Cosmo Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMOPF, twice per month. The most recent reporting period available is July, 31 2025.




This page (OTC:CMOPF) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners